Screening for Nonmedical Use and Misuse of Prescription Medication by Adolescents
Authors:
- 4 December 2024
- journal article
- research article
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 46 (2) , 357-363
Abstract
Background: Several screening tools have been developed to identify youth with alcohol, cannabis, and tobacco/nicotine use disorders, although less attention has been paid to other substances, including the nonmedical use of prescription medication or prescription medication misuse. Objective: To evaluate the proportion of youth reporting the use of substances other than alcohol, cannabis, and nicotine on 3 screening tools that have been developed and validated for identifying alcohol, cannabis, and nicotine use disorders among adolescent primary care patients. Methods: Adolescents (N = 757) from primary care pediatric practices were randomized to complete substance use screening tools (Screening to Brief Intervention [S2BI, N = 242], Brief Screener for Alcohol, Tobacco, and Other Drugs [BSTAD, N = 253], Tobacco, Alcohol, Prescription Medication, and Other Substance Use [TAPS, N = 262]) and then complete a brief electronic assessment battery and a structured diagnostic interview that assessed for past-year use of opioids and benzodiazepines. A total of 716 adolescents with complete data for each screening tool and the structured interview were analyzed for this report. Results: Rates of the nonmedical use of prescription medication or prescription medication misuse varied by tool: S2BI: 20 (8.5%), BSTAD: 4 (1.7%), and TAPS: 3 (1.3%). No participant endorsed benzodiazepine or opioid use on the World Mental Health Composite International Diagnostic Interview Substance Abuse Module. Conclusion: Rates of reporting the nonmedical use of prescription medication or prescription medication misuse vary by screen, and some exceed national estimates. Nonmedical use of prescription medication or prescription medication misuse may be more common than previously reported, although some responses may be false positives. Refining questions could elucidate an especially concerning behavior given widespread fentanyl contamination.Keywords
Funding Information
- National Institute on Drug Abuse (75N95019D00013)
- National Institute on Drug Abuse (HHSN271201400028C)
- National Institute on Drug Abuse (UG1DA015831)
This publication has 11 references indexed in Scilit:
- The Overdose Crisis among U.S. AdolescentsNew England Journal of Medicine, 2024
- Assessment of Screening Tools to Identify Substance Use Disorders Among AdolescentsJAMA Network Open, 2023
- Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021JAMA, 2022
- Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021Drug and Alcohol Dependence, 2022
- Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care PatientsAnnals of Internal Medicine, 2016
- Substance Use Screening, Brief Intervention, and Referral to TreatmentPediatrics, 2016
- Adolescent Substance Use Screening in Primary Care: Validity of Computer Self-Administered versus Clinician-Administered ScreeningSubstance Abuse, 2016
- An Electronic Screen for Triaging Adolescent Substance Use by Risk LevelsJAMA Pediatrics, 2014
- Validity of Brief Screening Instrument for Adolescent Tobacco, Alcohol, and Drug UsePediatrics, 2014
- Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health SurveysInternational Journal of Methods in Psychiatric Research, 2006